Fox J G, MacGregor J A, Shen Z, Li X, Lewis R, Dangler C A
Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge 02139, USA.
J Clin Microbiol. 1998 May;36(5):1382-7. doi: 10.1128/JCM.36.5.1382-1387.1998.
In a long-term rodent bioassay evaluating the carcinogenicity of triethanolamine, there was equivocal evidence of carcinogenic activity in male B6C3F1 mice, based on a marginal increase in the number of hepatocellular adenomas and hepatoblastomas. Interpretation was complicated by the presence of Helicobacter hepaticus in selected silver-stained liver sections which also had histological evidence of karyomegaly and oval cell hyperplasia. An increase in numbers of liver tumors, as evidence of carcinogenic activity, was also noted in female mice. However, H. hepaticus was not considered a complicating factor, because the livers of the female mice did not have histological features compatible with H. hepaticus infection. A retrospective analysis of 51 liver tissue samples from the original carcinogenicity study was conducted to determine the incidence of H. hepaticus infection and to evaluate different diagnostic approaches for assessing the presence of H. hepaticus in livers lacking characteristic lesions. In an initial evaluation of seven mice with liver tumors, argyrophilic bacteria resembling H. hepaticus were observed in liver sections, associated with characteristic liver lesions of hepatocytic karyomegaly and oval cell hyperplasia. Frozen liver tissue was available from four of these mice; all were confirmed to be infected with H. hepaticus by culture and PCR. In a larger subsequent analysis using frozen liver tissues from 44 mice without characteristic hepatic lesions, H. hepaticus-specific DNA was amplified from the livers of 21 of 44 of the mice (47%), compared to 14 of 44 of the mice (32%) having H. hepaticus cultured from their frozen liver tumors. The results of H. hepaticus culture and H. hepaticus-specific PCR concurred (i.e., both positive and negative results) in 84% of the cases. Microscopic detection of immunofluorescence-labeled or silver-stained bacteria in liver sections was relatively insensitive compared to either culture or PCR detection. This study confirms the widespread prevalence of H. hepaticus in mice, its potential to confound experimental results, and the need to include diagnostic testing for H. hepaticus in a murine health monitoring program.
在一项评估三乙醇胺致癌性的长期啮齿动物生物测定中,基于肝细胞腺瘤和肝母细胞瘤数量的少量增加,雄性B6C3F1小鼠存在模棱两可的致癌活性证据。选定的银染肝切片中存在肝螺杆菌,且这些切片同时具有核肿大和卵圆细胞增生的组织学证据,这使得解读变得复杂。雌性小鼠中也观察到肝脏肿瘤数量增加,作为致癌活性的证据。然而,肝螺杆菌不被视为一个复杂因素,因为雌性小鼠的肝脏没有与肝螺杆菌感染相符的组织学特征。对原致癌性研究中的51份肝组织样本进行了回顾性分析,以确定肝螺杆菌感染的发生率,并评估在缺乏特征性病变的肝脏中评估肝螺杆菌存在的不同诊断方法。在对7只患有肝脏肿瘤的小鼠进行的初步评估中,在肝切片中观察到类似肝螺杆菌的嗜银菌,伴有肝细胞核肿大和卵圆细胞增生的特征性肝脏病变。其中4只小鼠有冷冻肝组织;通过培养和PCR证实所有小鼠均感染了肝螺杆菌。在随后一项针对44只无特征性肝脏病变小鼠的更大规模分析中,44只小鼠中有21只(47%)的肝脏扩增出肝螺杆菌特异性DNA,相比之下,44只小鼠中有14只(32%)的冷冻肝脏肿瘤培养出肝螺杆菌。肝螺杆菌培养和肝螺杆菌特异性PCR的结果在84%的病例中一致(即均为阳性或均为阴性)。与培养或PCR检测相比,肝切片中免疫荧光标记或银染细菌的显微镜检测相对不敏感。这项研究证实了肝螺杆菌在小鼠中广泛存在,其有可能混淆实验结果,以及在小鼠健康监测计划中需要纳入肝螺杆菌的诊断检测。